## Abstract ## Objective Erdheim‐Chester disease (ECD) is a rare form of non–Langerhans' cell histiocytosis. The aim of this study was to assess the value of whole‐body scanning with ^18^F‐fluorodeoxyglucose–positron emission tomography (FDG‐PET) in a large cohort of ECD patients from a single cen
Is18F-fluorodeoxyglucose positron emission tomography meaningful for estimating the efficacy of corticosteroid therapy in patients with autoimmune pancreatitis?
✍ Scribed by Minoru Shigekawa; Kenji Yamao; Akira Sawaki; Kazuo Hara; Tadayuki Takagi; Vikram Bhatia; Masami Nishio; Tsuneo Tamaki; Hussein El-Amin; Zain EL-Abdeen Ahmed Sayed; Nobumasa Mizuno
- Publisher
- Springer Japan
- Year
- 2009
- Tongue
- English
- Weight
- 1012 KB
- Volume
- 17
- Category
- Article
- ISSN
- 1868-6974
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Background The aim of our study was to assess the value of positron emission tomography (PET) with 18F‐fluorodeoxyglucose (FDG) for the staging of clinically nodal negative necks in oral and oropharyngeal squamous cell carcinoma (SCC) using sentinel lymph node (SLN) biopsy and elect
## Abstract ## BACKGROUND To assess the ability of [^18^F]fluorodeoxyglucose (F‐18 FDG) positron emission tomography (PET) to predict the viability of residual masses after chemotherapy in patients with metastatic nonseminomatous germ cell tumors (GCT), PET results were compared in a blinded analy
## Abstract ## Background. Residual structural abnormalities after definitive treatment of head and neck squamous cell carcinoma (HNSCC) are common and pose difficult management problems. The usefulness of fluorine‐18 fluorodeoxyglucose positron emission tomography (FDG PET) to supplement conventi